AbdullinaAVasilevaEKulikovaE, et al. (2022) The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex. Journal of Psychopharmacology36(2): 1069101.
2.
DunnettDOloyedeEOduniyiO, et al. (2021) Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series. Journal of Psychopharmacology. Epub ahead of print 27October. DOI: 10.1177/02698811211050561.
3.
FehselKSchwankeKKappelBA, et al. (2022) Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction. Journal of Psychopharmacology. Epub aheadof print 3January. DOI: 10.1177/02698811211055811.
4.
GukasyanNAlan Kooi Davis FrederickSBarrett MaryP, et al. (2022) Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective twelve-month follow-up. Journal of Psychopharmacology36(2): 1–22.
5.
HanMLianJSuY, et al. (2021) Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats. Journal of Psychopharmacology. Epub ahead of print 25 October. DOI: 10.1177/02698811211050549.
6.
HighlandJNFarmerCAZanosP, et al. (2021) Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans. Journal of Psychopharmacology. Epub ahead of print 31 December. DOI: 10.1177/02698811211064922.
7.
LoureiroCMFachimHHarteMK, et al. (2022) Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats. Journal of Psychopharmacology36(2): 1–7.
8.
MaceSDzahiniOCorneliusV, et al. (2022) Incident infection during the first year of treatment: A comparison of clozapine and paliperidone palmitate long-acting injection. Journal of Psychopharmacology. Epub ahead of print 7 January. DOI: 10.1177/02698811211058973.
9.
MarianiNEversonJParianteC, et al. (2022) Modulation of microglial activation by antidepressants. Journal of Psychopharmacology36(2): 1–20.
10.
RekhiGTayJLeeJ, et al. (2022) Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia. Journal of Psychopharmacology. Epub ahead of print 3 January. DOI: 10.1177/02698811211055812.
11.
WollmerMANeumannIJungS, et al. (2022) Clinical effects of glabellar botulinum toxin injections in borderline personality disorder: A randomized controlled trial. Journal of Psychopharmacology36(1).
